Download presentation
Presentation is loading. Please wait.
1
Narcotic drugs introduction
Domina Petric, MD
2
Narcotic drugs and dopamine
Mesolimbic dopaminergic system is the main target for narcotic drugs. Ventral tegmental area (VTA) sends projections into the nucleus accumbens, amygdala, hippocampus and prefrontal cortex. Most of the VTA neurons excrete dopamine. Dopamine release in the mesolimbic dopaminergic system is very important for reward and motivation processing.
3
Reward Motivation Pleasure Euphoria Motor functioning Compulsion
Image source: QUORA Dopamine pathways: Reward Motivation Pleasure Euphoria Motor functioning Compulsion Perseveration Nucleus accumbens VTA
4
Narcotic drugs and dopamine
Narcotic drugs activate mesolimbic dopaminergic system (MDS). MDS is important in discernment between expected and real reward. MDS creates strong signal for learning process.
5
Narcotic drugs classification
that bind on the Gio-protein receptors. Narcotic drugs that act on the ionotropic receptors or ion channels. Narcotics that affect dopaminergic transporter (DTA).
6
Tolerance Dose of narcotic drugs must be increased
to maintain rewarding effect. This is called tolerance. Very fast development of tolerance is called tachyphylaxis.
7
Abstinence syndrome After cessation of taking narcotic drug, usually after relatively short period of time (specific for every drug), abstinence syndrome develops.
8
Addiction It is characterised with high motivation to get the narcotic drug despite negative consequences. With time drug abuse becomes compulsive (desire without pleasure).
9
Addiction High risk for relapses
LTP: long term potentiation, activation of NMDA receptors. LTP Nucleus accumbens Dopamine Addiction High risk for relapses Genetic predisposition
10
Katzung, Masters, Trevor.
Clinical pharmacology.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.